Why is Bandaram Pharma falling/rising?

As of 20-Jun, Bandaram Pharma Packtech Ltd's stock price is currently at Rs 41.40, reflecting an increase of Rs 1.46 or 3.66%. The stock has been gaining momentum, having outperformed its sector by 3.37% today and achieving a consecutive gain over the last two days with a total return of 6.98%. Despite today's volatility, where the stock reached a high of Rs 44 and a low of Rs 38.65, it has shown strong short-term performance with a 1-week return of 16.62% and a 1-month return of 5.21%. However, the stock's year-to-date performance remains negative at -6.76%, indicating some underlying challenges. The company's attractive valuation, with a return on capital employed (ROCE) of 6.2 and a favorable enterprise value to capital employed ratio, may be contributing positively to investor sentiment, despite a high debt to EBITDA ratio and flat quarterly results.
In the broader market context, Bandaram Pharma's recent performance has significantly outpaced the benchmark Sensex, which has only returned 1.59% over the past week. This strong relative performance could be attracting more attention from investors, particularly given the stock's 19.31% return over the past year compared to the market's 2.60%. However, the stock's long-term fundamentals appear weak, as indicated by its average ROCE and high debt levels, which may temper enthusiasm among more cautious investors. Overall, while the stock is experiencing a positive short-term movement, concerns regarding its long-term financial health could influence future price stability.